Music Therapist Helps Cancer Patients Speak Through Song

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 8 No 12
Volume 8
Issue 12

NEW YORK-The 24-year-old patient recuperating from a bone marrow transplant in a hospital room at Memorial Sloan-Kettering Cancer Center was depressed and not communicating. The staff thought Lucanne Magill, the hospital music therapist, could help.

NEW YORK—The 24-year-old patient recuperating from a bone marrow transplant in a hospital room at Memorial Sloan-Kettering Cancer Center was depressed and not communicating. The staff thought Lucanne Magill, the hospital music therapist, could help.

“I went four times to his room with my guitar to ask if he would like to hear a song,” Ms. Magill, who is a PhD candidate, said at a press briefing introducing Memorial’s new Integrative Medicine Service. “The fifth time, he said ‘Play if you want.’ So I sat in his room and played two soft songs that had to do with the mountains and countryside.”

One of the songs she chose was Take Me Home, Country Road “because I thought he might be thinking of going home.” During that song, he pulled out his tape recorder and began to record Ms. Magill as she sang. This was the beginning of a series of visits that were centered around music.

During one such visit, the patient told Ms. Magill he was very concerned about his marriage and didn’t know what to say to his wife anymore. She suggested he write his wife a song, but he said he did not know how to write songs. “So I told him to write her a letter, and I would put it to music. It took us about an hour.”

The song became a wonderful gift for him to give to his wife, she said, and it enhanced his self-esteem, as he was able to share the song with staff members whenever they entered his room. “It helped him build a network of support,” Ms. Magill said. “He began to feel freer to talk about his anger and frustration, and the process also helped him cope better with his pain and suffering.”

Music has the potential to soothe patients, distract them from their pain, and quickly change their mood, she said. “It helps reduce the sense of suffering that compounds the pain experience.”

Work With Children

Ms. Magill also works with outpatients and with families, including the young children of cancer patients. “I help them explore their fears and fantasies within the framework of music,” she said. “One little boy created his own fantasy song. It had to do with a person who was being killed in a war, and it exposed a lot of fear the child was having.”

Creating songs not only gives children a chance to reveal their feelings, she said, but also gives an opportunity for the music therapist to substitute reality for the child’s fantasies, which helps decrease their anxiety. “I remind children that their parent’s sickness has nothing to do with anything they’ve done, and that the parent still loves them,” Ms. Magill said. Just seeing the place where her mother was staying helped ease the fears of one little girl, she recalled.

Another little girl learned the song, Que Sera, which begins, “When I was just a little girl, I asked my mother—” and includes several characters. “All the characters in the song became important figures to the little girl and gave her strength,” Ms. Magill said.

Ms. Magill, who has worked at Memorial Sloan-Kettering for more than 2 decades, is now a part of the hospital’s new Integrative Medicine Service, which offers patients complementary therapies such as massage and meditation as well as music therapy and many others. (For other articles on this new service, see Oncology News International, Sept. 1999, page 1, and Nov. 1999, page 2.)

These therapies, Ms. Magill said, help patients “feel in touch with their own well being and sense of worth, which helps them cope and helps the medical treatment go smoothly.”

Recent Videos
Brett L. Ecker, MD, focused on the use of de-escalation therapy, which is gaining momentum in neuroendocrine tumors.
Immunotherapy options like CAR T-cell therapy and antigen-presenting cell-directed agents are currently being evaluated in the pancreatic cancer field.
Certain bridging therapies and abundant steroid use may complicate the T-cell collection process during CAR T therapy.
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
2 experts are featured in this video
2 experts are featured in this video
2 experts are featured in this video
4 KOLs are featured in this series.
Related Content